On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New CFO, Corporate Secretary

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced the appointment of a new chief financial officer and corporate secretary. The company named François C. Desrosiers, B. Com (Spec.) and FCSI, as Rryah CFO and … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New CFO, Corporate Secretary”

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New Director, CEO

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced that its board of directors has nominated Dr. David R. Richards, PhD, FIoD, FRSA, CPsych, as a new director and the company’s chief executive officer. Richards … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New Director, CEO”

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Registration in New Zealand for Proprietary IoT System

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a medical device certification in New Zealand for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). This comes in coordination with Medical Kiwi Ltd. … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Registration in New Zealand for Proprietary IoT System”

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device”

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Partners with University of Milan to Test, Evaluate New Line of Smart-Patch Wellness Products

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, will be collaborating with the University of Milan, Italy, on a new wellness line of topical patches. The partnership will be testing the permeation and effectiveness of the … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Partners with University of Milan to Test, Evaluate New Line of Smart-Patch Wellness Products”

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System

RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company’s IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System”

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement

RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet’s patients using RYAH Smart Inhalers and data analytics, once certified … Continue reading “CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement”

CannabisNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Innovative Portfolio Powers Research Insights

RYAH Group (CSE: RYAH) is the leader in volume-control technology for plant-based medicine. The company supports cannabis research for the treatment of cancer “with innovative technology that collects, analyzes and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of … Continue reading “CannabisNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Innovative Portfolio Powers Research Insights”

CannabisNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Smart Dry Herb Inhaler Providing Consistent, Predictable Results

RYAH Group (CSE: RYAH) develops innovative IoT products that capture powerful data insights and is on a mission to transform patient care using big data and AI to reshape the understanding and uses of plant-based medicines. The company’s devices and data are being used by a rapidly growing number of participants in plant-based clinical trials … Continue reading “CannabisNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Smart Dry Herb Inhaler Providing Consistent, Predictable Results”

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer … Continue reading “RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects”

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722